跳至主要内容
临床试验/NCT01426672
NCT01426672已完成1 期

Monovision for Treatment of Diplopia

Mount Sinai Hospital, Canada2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年1月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Patients satisfaction with monovision was measured by standardized diplopia questionnaire and results reported in statistical terms on multiple measures tested on the questionnaire.

研究概览

简要总结

PURPOSE:

The purpose of this study is to quantitatively assess the efficacy of monovision correction in the treatment of acquired small angle binocular diplopia in adult patients.

METHOD:

Twenty patients with symptomatic diplopia were enrolled in a prospective treatment trial. All had stable deviations of 10 prism diopters or less for over three months. Each received monovision spectacles and/ or contact lenses with distance correction in the dominant eye. Half received a +3.00 diopter (D) add and the others received +2.50 D. The validated and standardized Diplopia Questionnaire and Amblyopia and Strabismus Questionnaire (ASQE) were used to quantify the efficacy of monovision correction for diplopia by measuring the functional impact on vision-specific quality of life.

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Strabismic Deviation less than 12 Prism Diopters

排除标准

  • Inability to sign informed consent

研究组 & 干预措施

Monovision Correctoin

Experimental

Monovision correction

干预措施: Monovision Correction (with the help of glasses or contact lenses) (Other)

结局指标

主要结局

Patients satisfaction with monovision was measured by standardized diplopia questionnaire and results reported in statistical terms on multiple measures tested on the questionnaire.

时间窗: 2 years

To determine whether monovision correction was useful for the correction of small angle deviations in strabismic patients

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Monovision for the Treatment of Diplopia | 临床试验